TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10816404

Group type: EXPERIMENTAL
Intervention: Digital imaging (Group B)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional X-ray (Group A)
Number of subjects: 144
Study: 8870544

Group type: EXPERIMENTAL
Intervention: Long-term psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualifications of providers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical judgment versus case management
Number of subjects: 0
Study: 1517643

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) 100 mg by mouth twice daily
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Buprenorphine (Bu) 0.2 mg sublingually twice daily
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combined therapy (PHT 50 mg PO + Bu 0.1 mg SL twice daily)
Number of subjects: 75
Study: 6149671

Group type: EXPERIMENTAL
Intervention: Prenalterol (100‐200 mg daily)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intensified treatment with diuretics
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Prenalterol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control periods / intensified conventional treatment
Number of subjects: 10
Study: 30412325

Group type: EXPERIMENTAL
Intervention: Elbasvir/grazoprevir (EBR/GZR) for 12 weeks
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Baseline viral load cutpoint of 800,000 IU/mL
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Baseline NS5A resistance‐associated substitutions (RASs)
Number of subjects: 957
Study: 28436380

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) monotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Entecavir-adefovir dipivoxil (ETV-ADV) combination therapy
Number of subjects: 60
Study: 28091491

Group type: EXPERIMENTAL
Intervention: SMC‐phoresis of the bromine‐chlorine brine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard pharmaceutical treatment for IBS (myotropic anti‐spasmodics and lactulose)
Number of subjects: 80
Study: 25534310

Group type: EXPERIMENTAL
Intervention: Out & Online program (online mental health and wellbeing program)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 200
Study: 22281004

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg for the first two weeks, 10 mg for the last two weeks)
Number of subjects: 21
Study: 20133263

Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel weekly for 12 weeks followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) every 3 weeks for 4 cycles
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: FEC
Number of subjects: 66
Study: 18751500

Group type: EXPERIMENTAL
Intervention: Test formulation containing 400 mg dexibuprofen
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation containing 400 mg dexibuprofen
Number of subjects: 24
Study: 15933924

Group type: COMPARATOR
Intervention: HUT (Helicobacter urease testing)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: GBT (gastroscopic breath testing)
Number of subjects: 119

Group type: COMPARATOR
Intervention: HUT
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: GBT
Number of subjects: 119
Study: 12873919

Group type: EXPERIMENTAL
Intervention: 0.125% levobupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.20% levobupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.25% levobupivacaine
Number of subjects: 60
Study: 10372564

Group type: EXPERIMENTAL
Intervention: Gabapentin (600, 1200, or 2400 mg/day)
Number of subjects: 201
Study: 8908676

Group type: EXPERIMENTAL
Intervention: LHRH agonist leuprolide depot for 24 weeks
Number of subjects: 41
Study: 1677168

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Idazoxan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maprotiline (active control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine, Idazoxan, Maprotiline
Number of subjects: 0
Study: 31563241

Group type: EXPERIMENTAL
Intervention: Twice-Daily Tacrolimus (Prograf)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Once-Daily Tacrolimus (Advagraf)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Twice-Daily and Once-Daily Tacrolimus)
Number of subjects: 40
Study: 28420367

Group type: EXPERIMENTAL
Intervention: iFightDepression (iFD) tool + Treatment as Usual (TAU)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Internet-based psychoeducation + Treatment as Usual (TAU)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: iFightDepression (iFD) tool + TAU
Number of subjects: 310

Group type: COMPARATOR
Intervention: Internet-based psychoeducation + TAU
Number of subjects: 310
Study: 25377349

Group type: EXPERIMENTAL
Intervention: Cuidando a mis Cuidadores (Caring for My Caregivers) intervention, 8 sessions including skill-building workshops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 23525950

Group type: EXPERIMENTAL
Intervention: rs2494262 of the FCER1A gene
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: rs2427824 of the FCER1A gene
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: SNPs in IL10, ADAM33, NOS1 and IL4R
Number of subjects: 562
Study: 21306473

Group type: EXPERIMENTAL
Intervention: Caudal morphine-bupivacaine (100 μg·kg(‐1) morphine, mixed with 0.25% bupivacaine with 1 : 200,000 epinephrine)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intravenous morphine (150 μg·kg(‐1)) with droperidol (75 μg·kg(‐1))
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Caudal morphine-bupivacaine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 64
Study: 19687165

Group type: EXPERIMENTAL
Intervention: Atenolol-based regimen
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: Losartan-based regimen
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: QRS duration
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: Baseline QRS duration
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: Changes in ECG LVH severity
Number of subjects: 9193
Study: 17881400

Group type: COMPARATOR
Intervention: IVIG 150 mg/kg on Day 1, placebo on Days 2 and 3 (Group I)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: IVIG 450 mg/kg on Day 1, 300 mg/kg on Day 2, 150 mg/kg on Day 3 (Group II)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: IVIG treatment (both groups)
Number of subjects: 173
Study: 15473454

Group type: EXPERIMENTAL
Intervention: Ice
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water
Number of subjects: 20
Study: 11558817

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005% once daily plus timolol 0.5% twice daily
Number of subjects: 148

Group type: COMPARATOR
Intervention: dorzolamide 2% twice daily plus timolol 0.5% twice daily
Number of subjects: 148
Study: 9491039

Group type: EXPERIMENTAL
Intervention: Frozen solution (FS)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Conventional glucose electrolyte solution (CS)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Frozen solution (FS) after crossover from CS
Number of subjects: 91

Group type: COMPARATOR
Intervention: Conventional glucose electrolyte solution (CS) after crossover from FS
Number of subjects: 91
Study: 7870490

Group type: EXPERIMENTAL
Intervention: Mellow music
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Frenetic music
Number of subjects: 60

Group type: COMPARATOR
Intervention: White noise (control)
Number of subjects: 60
Study: 3163133

Group type: EXPERIMENTAL
Intervention: High-dose cytotoxic therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference group with long-term hospitalization
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference groups
Number of subjects: 20
Study: 31748424

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia plus 7% lidocaine cream applied around the chest tube insertion site 20 min before removal (Group L)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural anesthesia plus placebo cream (Group P)
Number of subjects: 40
Study: 28976835

Group type: EXPERIMENTAL
Intervention: Cryopreserved human umbilical cord (cUC) allograft with negative pressure wound therapy (NPWT)
Number of subjects: 13
Study: 25800685

Group type: EXPERIMENTAL
Intervention: IV glutamine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Ca/Mg infusion
Number of subjects: 55
Study: 23907080

Group type: EXPERIMENTAL
Intervention: Sleep group
Number of subjects: 24

Group type: COMPARATOR
Intervention: No-sleep group
Number of subjects: 24
Study: 21294018

Group type: EXPERIMENTAL
Intervention: Ergonomic chair and notebook riser with participatory ergonomics training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDA data adjusted for hours of computer use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no ergonomic intervention)
Number of subjects: 0
Study: 19293352

Group type: EXPERIMENTAL
Intervention: Lactate (Lac) solution
Number of subjects: 13

Group type: COMPARATOR
Intervention: Lactate/bicarbonate (Lac/Bic) solution
Number of subjects: 13
Study: 16400650

Group type: EXPERIMENTAL
Intervention: Menatetrenone (45 mg daily)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no menatetrenone)
Number of subjects: 61
Study: 15523321

Group type: EXPERIMENTAL
Intervention: Intermittent intravenous low-dose dobutamine therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 20
Study: 11354888

Group type: EXPERIMENTAL
Intervention: Diets high in oleic acid, alpha-linolenic acid, fish or fish oil, and near-vegetarian diets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cholesterol-lowering diet
Number of subjects: 0
Study: 9304358

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg i.v. 10 min before induction of anaesthesia (Group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg i.v. 10 min before end of surgery (Group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo at both administration times (Group C)
Number of subjects: 120
Study: 8279987

Group type: EXPERIMENTAL
Intervention: bezafibrate (200mg t.i.d.)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: simvastatin (10-40mg q.p.m.)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 126
Study: 3820443

Group type: EXPERIMENTAL
Intervention: High-dose bismuth subsalicylate (2 tablets, 262 mg each, four times daily)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Low-dose bismuth subsalicylate (1 tablet, 262 mg each, four times daily)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo (four times daily)
Number of subjects: 182
Study: 31047791

Group type: EXPERIMENTAL
Intervention: Adaptive tutorials
Number of subjects: 81

Group type: COMPARATOR
Intervention: Peer-reviewed web-based resources
Number of subjects: 81
Study: 27912106

Group type: EXPERIMENTAL
Intervention: Bright light therapy (BLT); details on dosage and duration not available.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified; details not available.
Number of subjects: 0
Study: 25791322

Group type: EXPERIMENTAL
Intervention: Realistic simulation design
Number of subjects: 153

Group type: COMPARATOR
Intervention: Unrealistic simulation design
Number of subjects: 153
Study: 24217748

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no non-nutritive sucking)
Number of subjects: 20
Study: 21478735

Group type: EXPERIMENTAL
Intervention: Perioperative stroke
Number of subjects: 523059
Study: 19828899

Group type: EXPERIMENTAL
Intervention: Dairy-rich, high fruits and vegetables diet (D-FandV; 30% fat, 7% saturated fat, 3.4 servings/d dairy)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High fruits and vegetables diet (FandV; 30% fat, 7% SFA, 0.4 servings/d dairy)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Average Western diet (control; 36% fat, 15% SFA, 0.4 servings/d dairy)
Number of subjects: 23
Study: 16112215

Group type: COMPARATOR
Intervention: MMN component analysis in linguistic stimuli
Number of subjects: 31

Group type: COMPARATOR
Intervention: LDN component analysis in both types of stimuli
Number of subjects: 31

Group type: COMPARATOR
Intervention: Syllable processing
Number of subjects: 31

Group type: COMPARATOR
Intervention: Complex tone processing
Number of subjects: 31
Study: 15183924

Group type: EXPERIMENTAL
Intervention: Chewing a piece of tasteless chewing gum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chewing a piece of spearmint flavoured chewing gum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mimicking chewing movements
Number of subjects: 0

Group type: COMPARATOR
Intervention: No chewing
Number of subjects: 0
Study: 11579069

Group type: EXPERIMENTAL
Intervention: VISA-A questionnaire in non-surgical patients
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: VISA-A questionnaire in presurgical patients
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control subjects (normal population)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Comparison of non-surgical patients to presurgical patients
Number of subjects: 45

Group type: COMPARATOR
Intervention: Comparison of control subjects to both patient populations
Number of subjects: 45
Study: 9641189

Group type: EXPERIMENTAL
Intervention: Desferrioxamine 0.5 mg/kg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Desferrioxamine 2.5 mg/kg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Desferrioxamine 5.0 mg/kg
Number of subjects: 5
Study: 8087679

Group type: EXPERIMENTAL
Intervention: Regular-strength chlorhexidine mouthrinse (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-concentration chlorhexidine mouthrinses (Groups A and C)
Number of subjects: 0
Study: 2533803

Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg) + Diazepam (5 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg) + Meclophenoxate (100 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 335940

Group type: EXPERIMENTAL
Intervention: Folic acid added to wine (10 microgram/ml)
Number of subjects: 13
Study: 31981604

Group type: EXPERIMENTAL
Intervention: Brix 3000
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 2.25% sodium hypochlorite gel
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 32
Study: 28418157

Group type: EXPERIMENTAL
Intervention: TRUShape
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vortex
Number of subjects: 20
Study: 28631933

Group type: EXPERIMENTAL
Intervention: SaltSwitch smartphone app
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 66
Study: 26678525

Group type: EXPERIMENTAL
Intervention: 400 μg hydroxycobalamin intramuscularly
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham injection (placebo)
Number of subjects: 80
Study: 23158835

Group type: EXPERIMENTAL
Intervention: Errorless learning (EL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Symptom management training (Control)
Number of subjects: 60
Study: 21514842

Group type: EXPERIMENTAL
Intervention: Modified port implantation using a suture-mediated closure system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional port implantation
Number of subjects: 40
Study: 18073464

Group type: EXPERIMENTAL
Intervention: Upper extremity treatment protocols involving EMG‐triggered neuromuscular stimulation and coupled bilateral movements
Number of subjects: 16
Study: 17066490

Group type: EXPERIMENTAL
Intervention: Standard Treatment (ST)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Standard Treatment plus Brief Feedback (BF)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Brief Feedback plus Contingent Monetary Reinforcement (CM)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Cigarettes
Number of subjects: 97

Group type: COMPARATOR
Intervention: Nicotine Gum
Number of subjects: 97
Study: 12615581

Group type: EXPERIMENTAL
Intervention: Aminophylline 250 mg
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 11444269

Group type: EXPERIMENTAL
Intervention: Acitretin (20 mg/day, two 10 mg tablets daily)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (tablets without acitretin)
Number of subjects: 21
Study: 9340174

Group type: EXPERIMENTAL
Intervention: Metoprolol (150 mg twice daily for 2 days)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Verapamil (80 mg every 6 hours for 2 days)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Untreated patients (drug free arm)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 17
Study: 1337423

Group type: EXPERIMENTAL
Intervention: L-648,051
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diluent
Number of subjects: 12
Study: 3510475

Group type: EXPERIMENTAL
Intervention: Oxacillin (200 mg/kg/day by six bolus intravenous injections for 24 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no oxacillin)
Number of subjects: 60
Study: 29072372

Group type: EXPERIMENTAL
Intervention: Misoprostol treatment (800 μg vaginally)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 184
Study: 27192770

Group type: EXPERIMENTAL
Intervention: Patellar resurfacing (62 cases)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Patellar retention (61 cases)
Number of subjects: 114
Study: 24423835

Group type: EXPERIMENTAL
Intervention: Clinically approved plan using forward planning method (FP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Hybrid intensity-modulated radiation therapy (IMRT) plan with flat beam open fields combined with nonflat beam IMRT fields (mixed DAO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Hybrid IMRT plan with both open and IMRT fields from nonflat beams (nonflat DAO)
Number of subjects: 15

Group type: COMPARATOR
Intervention: All plans (FP, mixed DAO, nonflat DAO)
Number of subjects: 15
Study: 23430163

Group type: EXPERIMENTAL
Intervention: Tapentadol (25, 50, and 75 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Tramadol (50, 100, and 150 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydromorphone (2, 4, and 6 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 21242821

Group type: EXPERIMENTAL
Intervention: Acupuncture in addition to self-care for a period of 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Self-care only
Number of subjects: 72
Study: 18326503

Group type: EXPERIMENTAL
Intervention: Telling patients their lung age after spirometric assessment
Number of subjects: 561

Group type: COMPARATOR
Intervention: Control group received raw FEV1 figure
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Telling patients their lung age
Number of subjects: 561
Study: 16496118

Group type: EXPERIMENTAL
Intervention: Nasal dilator strips (NDSs)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (nonspecific education about sleep disorders)
Number of subjects: 80
Study: 14557363

Group type: EXPERIMENTAL
Intervention: Small resistance arteries with M/L ratio greater than mean (0.098) or mean +2 SD (0.11)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Small resistance arteries with M/L ratio less than mean (0.098) or mean +2 SD (0.11)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Pulse pressure
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: M/L ratio
Number of subjects: 128
Study: 11061732

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 7487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7487
Study: 1411296

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 3813191

Group type: EXPERIMENTAL
Intervention: Uniphyl (once daily at 8 P.M.)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Theo-Dur (twice daily at 8 A.M. and 8 P.M.)
Number of subjects: 22
Study: 28681996

Group type: EXPERIMENTAL
Intervention: (pyr1)-Apelin-13 9 nmol/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: (pyr1)-Apelin-13 30 nmol/kg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 27273646

Group type: EXPERIMENTAL
Intervention: PRIME intervention (training in fever case management using malaria rapid diagnostic tests, patient-centered services, health center management, provision of mRDTs and artemether-lumefantrine)
Number of subjects: 992

Group type: COMPARATOR
Intervention: Control group (standard care without the PRIME intervention)
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: PRIME intervention
Number of subjects: 992
Study: 24401049

Group type: EXPERIMENTAL
Intervention: Tight glycemic control (target blood glucose range of 72 to 126 mg/dL)
Number of subjects: 1369

Group type: COMPARATOR
Intervention: Conventional glycemic control (target blood glucose level below 216 mg/dL)
Number of subjects: 1369

Group type: EXPERIMENTAL
Intervention: Tight glycemic control
Number of subjects: 1369

Group type: COMPARATOR
Intervention: Conventional glycemic control
Number of subjects: 1369
Study: 22913550

Group type: EXPERIMENTAL
Intervention: Self-paced games
Number of subjects: 12
Study: 20538073

Group type: EXPERIMENTAL
Intervention: Enterra gastric stimulation system (GES) turned on for 6 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Enterra gastric stimulation system (GES) turned off during cross-over period
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Enterra gastric stimulation system (GES) turned on after 1 year
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Enterra gastric stimulation system (GES)
Number of subjects: 55
Study: 18468933

Group type: EXPERIMENTAL
Intervention: Training programme (eight sessions, followed by training twice a week for 30‐45 minutes at home at the level of the ventilatory threshold [V(T)])
Number of subjects: 25

Group type: COMPARATOR
Intervention: Usual routine treatment
Number of subjects: 25
Study: 16428086

Group type: EXPERIMENTAL
Intervention: G. lucidum polysaccharides at 5.4 g/day for 12 weeks
Number of subjects: 47
Study: 14659379

Group type: EXPERIMENTAL
Intervention: Qi-therapy
Number of subjects: 94

Group type: COMPARATOR
Intervention: Mimic therapy
Number of subjects: 94
Study: 10081535

Group type: EXPERIMENTAL
Intervention: PEEP = 10 cmH2O
Number of subjects: 13

Group type: COMPARATOR
Intervention: PEEP = 0 cmH2O
Number of subjects: 13
Study: 7752752

Group type: EXPERIMENTAL
Intervention: MMF 2 g
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: MMF 3 g
Number of subjects: 491

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 491